TAGS "BioNTech"
All News BioNTech In Focus BioNTech BreakingNews of BioNTech Your Interested Follow Story BioNTech
Roundup: U.S. forced into head-on combat with COVID-19 as cases hike in holiday season
Roundup: U.S. forced into head-on combat with COVID-19 as cases hike in holiday season
THURSDAY, NOVEMBER 25, 2021
Anthony Fauci, U.S. President Joe Bidens chief medical adviser, says that the "overwhelming majority" of vaccinated Americans should receive a booster dose, adding the definition of a full vaccination could expand to include three doses of an mRNA vaccine such as those from Pfizer-BioNTech or Moderna, or two doses of the J&J vaccine.U.S. authorizes Pfizer/BioNTech, Moderna COVID-19 vaccine boosters for all adults
U.S. authorizes Pfizer/BioNTech, Moderna COVID-19 vaccine boosters for all adults
SATURDAY, NOVEMBER 20, 2021
If CDC Director Rochelle Walensky signs off on broader use, the extra shots could be available for all adults as soon as this weekend.Pfizer asks U.S. FDA to authorize COVID-19 booster for all 18 and up
Pfizer asks U.S. FDA to authorize COVID-19 booster for all 18 and up
WEDNESDAY, NOVEMBER 10, 2021
The new request from Pfizer and BioNTech came as "federal health officials have made clear their concern about waning immunity as the nation heads into the winter months," reported CNN.U.S. ramps up efforts on vaccination, mandate, test to counter COVID-19 ahead of winter
U.S. ramps up efforts on vaccination, mandate, test to counter COVID-19 ahead of winter
FRIDAY, OCTOBER 08, 2021
Pfizer and BioNTech said that they are seeking the U.S. Food and Drug Administration emergency use authorization for their COVID-19 vaccine for children ages 5 to 11. If authorized, this would be the first COVID-19 vaccine for younger children.Pfizer, BioNTech ask FDA to authorize vaccine for children 5 to 11
Pfizer, BioNTech ask FDA to authorize vaccine for children 5 to 11
FRIDAY, OCTOBER 08, 2021
U.S. pharmaceutical firm Pfizer and its German partner, BioNTech, have asked the Food and Drug Administration to authorize their coronavirus vaccine for emergency use for children 5 to 11 years old, the companies announced Thursday.EU medicines agency approves booster COVID-19 vaccine doses for adults
EU medicines agency approves booster COVID-19 vaccine doses for adults
TUESDAY, OCTOBER 05, 2021
The European Medicines Agency approved booster doses of the Pfizer/BioNTech COVID-19 vaccine for all people aged 18 and over, recommending the booster doses be considered at least 6 months after the second dose.Vaccine developer BioNTechs revenues jump to 5.3 bln euros in Q2
Vaccine developer BioNTechs revenues jump to 5.3 bln euros in Q2
TUESDAY, AUGUST 10, 2021
The companys estimated net income in Q2 skyrocketed to 2.8 billion euros due to sales from its COVID-19 vaccine.THG confirms deal for 20m BioNTech doses, 1st batch expected this month
THG confirms deal for 20m BioNTech doses, 1st batch expected this month
THURSDAY, JULY 15, 2021
Thonburi Healthcare Group (THG) chairman Boon Vanasin on Thursday confirmed that THG will sign a deal with Germany BioNTech to import 20 million doses of Covid-19 vaccine to Thailand.Pfizer-BioNTech vaccine safe and effective in children as young as 12, say companies
Pfizer-BioNTech vaccine safe and effective in children as young as 12, say companies
WEDNESDAY, MARCH 31, 2021
The Pfizer-BioNTech vaccine was safe and effective in adolescents as young as 12, the drug companies announced Wednesday in a joint news release.BioNTech raises covid vaccine target to 2.5 billion doses
BioNTech raises covid vaccine target to 2.5 billion doses
TUESDAY, MARCH 30, 2021
BioNTech and Pfizer raised this year's production target for their covid-19 vaccine to as many as 2.5 billion doses, with the biotech's chief executive predicting a version of the shot that can be stored in refrigerators will be ready within months.